“hepatitis-c” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
Elliott Sigal, Bristol’s Former R&D Chief, on Life After Big Pharma 02/25/14 New York
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Gilead Wins FDA Approval for Big Hepatitis C Drug 12/06/13 San Francisco
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Vertex Sells Hep C Drug Royalty Rights to Janssen for $152M 11/20/13 Boston
Bristol-Myers Cuts Clinical Team at ZymoGenetics Seattle Site 11/07/13 Seattle
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Vertex Sees Liver Toxicity With Emerging Hep C Drug, Faces FDA Hold 07/25/13 Boston
How to Save $200 Billion and Cure Hepatitis C 07/22/13 Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
East Coast Life Sciences Roundup: Blend, Amicus, Vertex, & More 12/21/12 Boston
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Hepatitis C Treatments from Gilead, Abbott Wow Liver Meeting 11/13/12 Boston
East Coast Life Sciences Roundup: Vertex, Thermedical, More 11/02/12 Boston
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Clarus Ventures Adjusts to Unpredictable Biotech World 01/20/12 Boston
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs 01/19/12 New York
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
Page 3 of 9 « previous page · next page »